Concepedia

Rolf Ostendorf

RO

3

Publications

191

Citations

3

H-Index

2016

Active since

Affiliations

University of Wuppertal(Current)

Witten/Herdecke University

München Klinik

Biofrontera (Germany)

Klinikum Vest

Rolf Ostendorf is an author at University of Wuppertal.

Publications per year

2016–2019

3

Publications

3

A randomized, double‐blind, phase <scp>III</scp> , multicentre study to evaluate the safety and efficacy of <scp>BF</scp> ‐200 <scp>ALA</scp> (Ameluz <sup>®</sup> ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the <scp>BF</scp> ‐Rhodo <scp>LED</scp> <sup>®</sup> lamp

Uwe Reinhold, Thomas Dirschka, Rolf Ostendorf et al. · British Journal of Dermatology · 2016 · 89 citations · Full text

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy

C.A. Morton, R. Dominicus, Peter Radny et al. · British Journal of Dermatology · 2018 · 70 citations · Full text

Long‐term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials

Harald Gollnick, Thomas Dirschka, Rolf Ostendorf et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 32 citations · Full text

Rows per page

1–3 of 3